Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Clinical Trials in St Louis, Missouri
2 recruitingSt Louis, Missouri
Showing 1–2 of 2 trials
Recruiting
Phase 2
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRefractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Diffuse Large B-Cell Lymphoma+12 more
National Cancer Institute (NCI)120 enrolled82 locationsNCT06649812
Recruiting
Phase 2
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Academic and Community Cancer Research United120 enrolled6 locationsNCT06238648